FSI et al. invest €40m in Cerenis Therapeutics
The Fund for Strategic Investment (FSI) and existing investors have provided French biopharma Cerenis Therapeutics with a €40m series-C round of funding.
More on France
Raise heads for second close for debut impact VC fund
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Cathay Capital launches EUR 500m health fund
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets
Montagu launches Arkopharma sale; attracts PE and trade buyers
Bridgepoint and CVC’s Cooper among parties interested in the natural medicines and food supplements maker
BC Partners, Ardian among sponsors in second round of Simago sale
Antin and Eurazeo also in race for minority stake in the French medical imaging specialist
Latest News
Raise heads for second close for debut impact VC fund
French sponsor seeks to attract state-backed LPs for new strategy targeting ESG-focused startups
Graphite makes value creation and investment team hires
Director appointments include Rutland Partners' Matt Hamilton-Allen, who joins the investment team
Pantheon closes private debt secondary fund on USD 834m
New vehicle exceeded target by more than USD 300m; aims for up to 20% exposure to European debt
Cathay Capital launches EUR 500m health fund
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets